Small-Vessel Vasculitis Studies

If you are interested in learning more about a study, email our research group at

Study Name

Currently Enrolling

Disease Studied

Drug Study

Study to Investigate the Efficacy and Safety of NS-229 in the Treatment of Eosinophilic Granulomatosis with Polyangiitis YES EGPA YES
Determinants of Systemic Immune Reactivation in ANCA Associated Vasculitis (DORA) YES GPA, MPA, EGPA NO
The Assessment of Prednisone in Remission Trial (TAPIR) NO GPA YES
5506: The EGPA Registry YES EGPA NO
Nasal Microbiome in ANCA Associated Vasculitis and Relapsing Polychondritis (NMB) YES EGPA & RP NO
Low Dose Naltrexone to Improve Physical Health in Patients With Vasculitis (LoDoNaVasc) YES GPA, MPA, EGPA, GCA, TAK, PAN YES
One-Time DNA Study for Vasculitis (OTD) YES GPA, MPA, EGPA, GCA, TAK, PAN NO
Clinical Transcriptomics in Systemic Vasculitis (CUTIS) YES GPA, MPA, EGPA, PAN, IgAV, cryoglobulinemic, drug-induced, isolated cutaneous small vessel vasculitis, urticarial NO
Tissue Repository Collection Protocol YES GPA, MPA, EGPA, GCA, TAK, PAN, cutaneous vasculitis NO
A Randomized Multicenter Study for Isolated Skin Vasculitis (ARAMIS) YES Cutaneous small/medium vessel vasculitis, cPAN, or IgA vasculitis YES
Depemokimab compared with mepolizumab for relapsing or refractory EGPA on standard of care therapy (OCEAN) YES EGPA YES